CA
NZ
UK
AU
IND
US
…
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
GelStat Corp (GSAC.US) is an OTC Pink‑listed micro‑cap company for which publicly available disclosures about business activities and products are minimal. Long‑term value may depend on successful development or commercialization of its offerings, obtaining regulatory clearances and distribution or licensing agreements, which could support revenue growth and licensing upside.
Major risks include very low liquidity, reliance on external financing with likely dilution, an unproven commercial track record, and regulatory and execution uncertainty that could impair value.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.33M | -0.37M | -0.21M | -0.76M | - |
| Net income | -0.33M | -0.37M | -0.21M | -0.76M | - |
| Selling general administrative | - | 0.17M | 0.02M | 0.05M | - |
| Selling and marketing expenses | - | 0.31M | 0.27M | 0.47M | - |
| Gross profit | -0.13M | 0.23M | 0.13M | -0.41M | - |
| Ebit | -0.24M | -0.28M | -0.16M | -0.59M | -0.31M |
| Ebitda | -0.21M | -0.25M | -0.15M | 0.01M | - |
| Depreciation and amortization | 0.03M | 0.03M | 0.01M | 0.60M | - |
| Operating income | -0.24M | -0.28M | -0.17M | -0.60M | - |
| Other operating expenses | 0.51M | 0.63M | 0.32M | 0.60M | - |
| Interest expense | 0.08M | 0.09M | 0.04M | 0.02M | 0.00M |
| Income tax expense | - | - | 0.00M | -0.45M | - |
| Total revenue | 0.27M | 0.35M | 0.15M | 0.00M | - |
| Total operating expenses | 0.11M | 0.51M | 0.30M | 0.19M | - |
| Cost of revenue | 0.40M | 0.12M | 0.02M | 0.41M | - |
| Total other income expense net | -0.08M | -0.09M | -0.04M | -0.16M | - |
| Net income applicable to common shares | - | - | - | - | -0.48M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.27M | 0.17M | 0.19M | 0.02M | - |
| Intangible assets | 0.07M | 0.10M | 0.14M | - | - |
| Other current assets | 0.16M | - | 0.00M | 0.00M | - |
| Total liab | 1.52M | 1.22M | 0.96M | 0.72M | - |
| Total stockholder equity | -1.25M | -1.05M | -0.78M | -0.71M | - |
| Other current liab | 0.45M | 0.32M | 0.32M | 0.28M | 0.02M |
| Common stock | 37.40M | 29.90M | 18.10M | 6.86M | 5.58M |
| Retained earnings | -21.14M | -20.82M | -20.45M | -20.24M | -19.47M |
| Other assets | - | - | 0.00M | - | 0.00M |
| Cash | 0.00M | 0.01M | 0.03M | 0.00M | - |
| Total current liabilities | 0.75M | 0.99M | 0.45M | 0.46M | 0.50M |
| Current deferred revenue | 0.01M | - | 0.01M | - | - |
| Net debt | 0.85M | 0.66M | 0.56M | 0.36M | - |
| Short term debt | 0.08M | 0.44M | 0.07M | 0.10M | - |
| Short long term debt total | 0.85M | 0.66M | 0.58M | 0.36M | - |
| Other stockholder equity | -17.10M | -9.82M | 1.96M | 12.67M | - |
| Property plant equipment | - | - | - | - | 0.04M |
| Total current assets | 0.18M | 0.07M | 0.05M | 0.00M | 0.14M |
| Net tangible assets | - | - | - | - | -0.33M |
| Short term investments | 0.00M | - | - | - | - |
| Net receivables | 0.02M | 0.06M | 0.02M | 0.00M | 0.00M |
| Inventory | - | - | -0.00M | -0.00M | 0.08M |
| Accounts payable | 0.20M | 0.23M | 0.06M | 0.08M | 0.06M |
| Accumulated other comprehensive income | -0.41M | -0.31M | -0.39M | - | - |
| Non currrent assets other | - | - | -0.00M | 0.00M | - |
| Non current assets total | 0.09M | 0.10M | 0.14M | 0.01M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Change to liabilities | - | - | - | - | 0.00M |
| Total cashflows from investing activities | -0.09M | - | - | - | - |
| Net borrowings | - | - | - | - | 0.17M |
| Total cash from financing activities | 0.14M | 0.04M | 0.13M | 0.11M | 0.27M |
| Change to operating activities | - | - | - | - | 0.10M |
| Net income | -0.33M | -0.37M | -0.21M | -0.76M | -0.48M |
| Change in cash | -0.00M | -0.02M | 0.02M | -0.07M | 0.07M |
| Begin period cash flow | 0.01M | 0.03M | 0.00M | 0.07M | - |
| End period cash flow | 0.00M | 0.01M | 0.03M | 0.00M | - |
| Total cash from operating activities | -0.06M | -0.06M | -0.11M | -0.17M | -0.20M |
| Depreciation | 0.03M | 0.06M | 0.05M | 0.08M | - |
| Other cashflows from investing activities | -0.07M | - | - | - | - |
| Change to inventory | - | - | - | 0.08M | 0.00M |
| Change to account receivables | 0.04M | -0.03M | -0.02M | 0.00M | -0.00M |
| Other cashflows from financing activities | - | - | -0.00M | - | - |
| Change to netincome | - | - | - | - | 0.12M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.05M | -0.03M | 0.00M | 0.18M | - |
| Stock based compensation | - | 0.08M | 0.01M | 0.24M | - |
| Other non cash items | 0.18M | 0.21M | 0.05M | 0.08M | - |
| Free cash flow | -0.06M | -0.06M | -0.11M | -0.17M | - |
Sector: Technology Industry: Software - Infrastructure
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| GSAC GelStat Corp |
- -% |
0.00 | - | - | 22.67 | - | 221.46 | -12.24 |
| MSFT Microsoft Corporation |
3.35 0.64% |
524.47 | 37.32 | 29.94 | 13.03 | 12.45 | 13.06 | 24.59 |
| ORCL Oracle Corporation |
-2.83 2.20% |
125.56 | 21.96 | 17.89 | 5.91 | 7.08 | 7.82 | 14.89 |
| CRWD Crowdstrike Holdings Inc |
-4.88 2.13% |
224.19 | 4849.80 | 188.68 | 46.01 | 47.24 | 43.89 | 559.34 |
| FTNT Fortinet Inc |
-0.67 0.52% |
127.43 | 60.27 | 43.86 | 16.80 | 80.50 | 16.11 | 43.33 |
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.
3557 SW Corporate Parkway, Palm City, FL, United States, 34990
772 283 0020
2
| Name | Title | Year Born |
|---|---|---|
| Mr. Javier G. Acosta | CEO & Director | NA |
| Mr. Charles F. Tarzian | Chief Marketing Advisor | 1957 |
| Dr. Roger K. Cady M.D. | Chief Medical Advisor | NA |
| Mr. Tim Sweeney | Consultant of Branding & Marketing | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.63%
Communication Services
-0.32%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.18%
Energy
+0.64%
Financial Services
-0.13%
Financials
-0.19%
Healthcare
-0.40%
Industrials
-0.00%
Real Estate
-0.34%
Technology
+0.25%
Utilities
-0.20%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...